CSIMarket Company Name, Ticker, Customers, else..


Aravive Inc   (ARAV)
Other Ticker:  
 

Aravive Inc

ARAV's Fundamental analysis



Aravive Inc 's sales fell by -44.39 % in III. Quarter 2023 from the same quarter a year ago. Ranking at No. 3662

Major Pharmaceutical Preparations industry recorded deterioration of revenues by -4.75 %

Aravive Inc realized net income compared to net loss a year ago in III. Quarter 2023

• More on ARAV's Growth


Aravive Inc
realized a net loss in trailing twelve months.

Aravive Inc realized cash reduction of $ -0.59 per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.44.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.76.


• More on ARAV's Valuation
 
 Total Debt (Millions $) -
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Revenue/Employee (TTM) $ -
 Net Income/Employee (TTM) $ -
 Receivable Turnover (TTM) -
 Tangible Book Value (Per Share $) 0.02

Aravive Inc
realized net loss in trailing twelve months.

Aravive Inc realized cash outflow of $ -0.59per share in trailing twelve-month period.
Company
-
PE TTM   
Industry
-
PE TTM    
Company's Price to Sales ratio is at 0.44.
Major Pharmaceutical Preparations industry's Price to Sales ratio is at 5.76.

Aravive Inc Price to Book Ratio is at 1.79 lower than Industry Avg. of 84.85. and higher than S&P 500 Avg. of 0

• More on ARAV's Valuation

•  Market Capitalization (Millions $) 3
•  Shares Outstanding (Millions) 76
•  Employees -
•  Revenues (TTM) (Millions $) 7
•  Net Income (TTM) (Millions $) -40
•  Cash Flow (TTM) (Millions $) -45
•  Capital Exp. (TTM) (Millions $) -
•  Total Debt (Millions $) -
•  Dividend TTM ($) 0 $
•  Dividend Yield TTM (%) -
•  Revenue/Employee (TTM) $ -
•  Net Income/Employee(TTM) $ -
•  Receivable Turnover Ratio (TTM) -
•  Tangible Book Value (Per Share $) 0.02

•  Market Capitalization (Millions $) 3
•  Shares Outstanding (Millions) 76
•  Employees -
•  Revenues (TTM) (Millions $) 7
•  Net Income (TTM) (Millions $) -40
•  Cash Flow (TTM) (Millions $) -45
•  Capital Exp. (TTM) (Millions $) -





  Ratio
•   Capital Ratio (MRQ) 0.98
•  Total Debt to Equity (MRQ) -
•  Tangible Leverage Ratio (MRQ) 6.67
•  Asset Turnover Ratio (TTM) 0.19
•  Inventory Turnover Ratio (TTM) -





Aravive Inc net profit margin of 770.17 % is currently ranking no. 7 in Major Pharmaceutical Preparations industry, ranking no. 9 in Healthcare sector and number 25 in S&P 500.

• More on ARAV's Key Ratios





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com